Risk factors for reflux esophagitis after eradication of Helicobacter pylori

References

• Asaka M, Kato M, Takahashi S, Japanese Society for Helicobacter Research, et al. Guidelines for the management of Helicobacter pylori infection in Japan: 2009 revised edition. Helicobacter. 2010;15(1):1–20.
   PubMed Web of Science ®Google Scholar
• Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001;345(11):784–789.
   PubMed Web of Science ®Google Scholar
• Nagasue T, Nakamura S, Kochi S, et al. Time trends of the impact of Helicobacter pylori infection and nonsteroidal anti-inflammatory drugs on peptic ulcer bleeding in Japanese patients. Digestion. 2015;91(1):37–41.
   PubMed Web of Science ®Google Scholar
• Nakamura S, Matsumoto T. Helicobacter pylori and gastric mucosa-associated lymphoid tissue lymphoma: recent progress in pathogenesis and management. WJG. 2013;19(45):8181–8187.
   PubMed Web of Science ®Google Scholar
• Ueda J, Gosho M, Inui Y, et al. Prevalence of Helicobacter pylori infection by birth year and geographic area in Japan. Helicobacter. 2014;19(2):105–110.
   PubMed Web of Science ®Google Scholar
• Labenz J, Malfertheiner P. Helicobacter pylori in gastro-oesophageal reflux disease: causal agent, independent or protective factor? Gut. 1997;41(3):277–280.
   PubMed Web of Science ®Google Scholar
• Iijima K, Ohara S, Koike T, et al. Gastric acid secretion of normal Japanese subjects in relation to Helicobacter pylori infection, aging, and gender. Scand J Gastroenterol. 2004;39(8):709–716.
   PubMed Web of Science ®Google Scholar
• Vakil N, van Zanten SV, Kahrilas P, Global Consensus Group, et al. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence- based consensus. Am J Gastroenterol. 2006;101(8):1900–1920.
   PubMed Web of Science ®Google Scholar
• Yaghoobi M, Farrokhyar F, Yuan Y, et al. Is there an increased risk of GERD after Helicobacter pylori eradication?: a meta-analysis. Am J Gastroenterol. 2010;105(5):1007–1013.
   PubMed Web of Science ®Google Scholar
• Saad AM, Choudhary A, Bechtold ML. Effect of Helicobacter pylori treatment on gastroesophageal reflux disease (GERD): meta-analysis of randomized controlled trials. Scand J Gastroenterol. 2012;47(2):129–135.
   PubMed Web of Science ®Google Scholar
• Nam SY, Choi IJ, Ryu KH, et al. Effect of Helicobacter pylori infection and its eradication on reflux esophagitis and reflux symptoms. Am J Gastroenterol. 2010;105(10):2153–2162.
   PubMed Web of Science ®Google Scholar
• Takeuchi R, Kato K, Mizuno S, et al. Abnormal gastroesophageal flap valve is highly associated with endoscopic reflux esophagitis after Helicobacter pylori eradication. Helicobacter. 2004;9(1):1–8.
   PubMed Web of Science ®Google Scholar
• Lundell LR, Dent J, Bennett JR, et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut. 1999;45(2):172–180.
   PubMed Web of Science ®Google Scholar
• Kimura K, Takemoto T. An endoscopic recognition of the atrophic border and its significance in chronic gastritis. Endoscopy. 1969;1(03):87–97.
   Google Scholar
• Xie T, Cui X, Zheng H, et al. Meta-analysis. Eradication of Helicobacter pylori infection is associated with the development of endoscopic gastroesophageal reflux disease. Eur J Gastroenterol Hepatol. 2013;25(10):1195–1205.
   PubMed Web of Science ®Google Scholar
• Qian B, Ma S, Shang L, et al. Effects of Helicobacter pylori eradication on gastroesophageal reflux disease. Helicobacter. 2011;16(4):255–265.
   PubMed Web of Science ®Google Scholar
• Murai T, Miwa H, Ohkura R, et al. The incidence of reflux oesophagitis after cure of Helicobacter pylori in a Japanese population. Aliment Pharmacol Ther. 2000;14(Suppl. 1):161–165.
   PubMed Web of Science ®Google Scholar
• Kawanishi M. Development of reflux esophagitis following Helicobacter pylori eradication. J Gastroenterol. 2005;40(11):1024–1028.
   PubMed Web of Science ®Google Scholar
• Hongo M, Traube M, McAllister RG, Jr, et al. Effects of nifedipine on esophageal motor function in humans: correlation with plasma nifedipine concentration. Gastroenterology. 1984;86(1):8–12.
   PubMed Web of Science ®Google Scholar
• Asaoka D, Nagahara A, Hojo M, et al. Association of medications for lifestyle-related diseases with reflux esophagitis. TCRM. 2016;12:1507–1515.
   Web of Science ®Google Scholar
• Miyamoto M, Haruma K, Kuwabara M, et al. High incidence of newly-developed gastroesophageal reflux disease in the Japanese community: a 6-year follow-up study. J Gastroenterol Hepatol. 2008;23(3):393–397.
   PubMed Web of Science ®Google Scholar
• Gunji T, Sato H, Iijima K, et al. Risk factors for erosive esophagitis: a cross-sectional study of a large number of Japanese males. J Gastroenterol. 2011;46(4):448–455.
   PubMed Web of Science ®Google Scholar
• Kawasaki K, Kurahara K, Yanai S, et al. Low-dose aspirin and non-steroidal anti-inflammatory drugs increase the risk of bleeding in patients with gastroduodenal ulcer. Dig Dis Sci. 2015;60(4):1010–1015.
   PubMed Web of Science ®Google Scholar
• Masuda T, Yano F, Omura N, et al. Effect of low-dose aspirin on chronic acid reflux esophagitis in rats. Dig Dis Sci. 2018;63(1):72–80.
   PubMed Web of Science ®Google Scholar
• Sugimoto M, Uotani T, Nishino M, et al. Antiplatelet drugs are a risk factor for esophageal mucosal injury. Digestion. 2013;87(4):281–289.
   PubMed Web of Science ®Google Scholar
• Hamada H, Haruma K, Mihara M, et al. High incidence of reflux oesophagitis after eradication therapy for Helicobacter pylori: impacts of hiatal hernia and corpus gastritis. Aliment Pharmacol Ther. 2000;14:729–735.
   PubMed Web of Science ®Google Scholar
• Gutierrez O, Melo M, Segura AM, et al. Cure of Helicobacter pylori infection improves gastric acid secretion in patients with corpus gastritis. Scand J Gastroenterol. 1997;32(7):664–668.
   PubMed Web of Science ®Google Scholar
• Kim BC, Song MA, Kwon SH, et al. Assessment of gastric acidity by conventional endoscopy with serological gastric markers. Gastroenterol Res. 2018;11(2):112–123.
   PubMed Web of Science ®Google Scholar
• Waldum HL, Hauso Ø, Fossmark R. The regulation of gastric acid secretion – clinical perspectives. Acta Physiol (Oxf). 2014;210(2):239–256.
   PubMed Web of Science ®Google Scholar
• El-Serag HB, Johanson JF. Risk factors for the severity of erosive esophagitis in Helicobacter pylori-negative patients with gastroesophageal reflux disease. Scand J Gastroenterol. 2002;37(8):899–904.
   PubMed Web of Science ®Google Scholar
• Koike T, Ohara S, Sekine H, et al. Increased gastric acid secretion after Helicobacter pylori eradication may be a factor for developing reflux oesophagitis. Aliment Pharmacol Ther. 2001;15(6):813–820.
   PubMed Web of Science ®Google Scholar
• Iijima K, Ohara S, Sekine H, Koike T, et al. Changes in gastric acid secretion assayed by endoscopic gastrin test before and after Helicobacter pylori eradication. Gut. 2000;46(1):20–26.
   PubMed Web of Science ®Google Scholar